Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Diagnostics is a leading developer, manufacturer, and marketer of serological and molecular biology tests—primarily ELISA and PCR kits—for the diagnosis of zoonotic diseases in humans and animals as well as veterinary diseases in farm animals. Their products are used globally to monitor animal health, control disease outbreaks, support eradication programs, verify vaccination campaigns' effectiveness, and detect emerging threats. The company is ISO 9001:2015 certified for all activities and ISO 13485:2016 certified for human health-related activities[1][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Diagnostics Technologies.